Logo Omnicell

Omnicell (OMCL) stock: analyst price target and their real reliability

Live quote · data updated Aug 28, 2026
Omnicell · Health Care · ref. ETF XLV · 68 calls · price $33.41
🏆JPI 2026 portfoliosSee tracking →
What the company does: Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally.

📈 Omnicell (OMCL) stock price

$33.41+0.4% over range
Aug 28, 25low $29.46 · high $51.39Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
100% recommend buying · 3 analysts
📊 JPI status : Omnicell is no longer in our current JPI rankings, but appeared in the past (2024) — its upside may be behind it. See the stocks picked in 2024 →

🎯 OMCL price target & analyst consensusprice $33.41

The price target · all analysts combined (3 targets)
Highest target · 1 firm of 3$65+94.6%
Median target · of 3 targets$50+49.7%
Lowest target · 1 firm of 3$45+34.7%
Current price$33.41
⭐ What the most reliable analysts say

No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.

The consensus · 3 ratings (last 6 months)
Strong Buy00%
Buy3100%
Hold00%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about Omnicell? The JPI assistant answers using our backtest data.

🔎 Detailed analyses

✅ Historical analyst reliability on OMCL

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm % right i Gain vs sector i Calls i
Cantor Fitzgerald  100% +52.3% 6
FBR Capital 67% +19.3% 3
Wells Fargo  50% -4.2% 10
Oppenheimer  50% -5.9% 2
Benchmark  47% +2.3% 19
Piper Sandler  45% -4.8% 11
Craig-Hallum  40% -13.3% 5
B of A Securities  0% -36.0% 2
BTIG  0% -44.5% 5
Keybanc  0% -49.5% 7

📊 What $1,000 invested in Omnicell would be worth › open the full page

In short — $1,000 invested in Omnicell 10 years ago would be worth $1,478 today, i.e. +4%/yr on average. Best year: 2021 (+50%), worst: 2022 (-72%). Price performance, excluding dividends.

If I'd invested $1,000 in Omnicell

InvestmentWorth todayGain
1 years ago$1,032+3%
3 years ago$911-9%
5 years ago$383-62%
→ See Omnicell's full return history + gain calculator

Return by year (Omnicell)

YearReturn$1,000 invested at year start
2026 (YTD)+1%$1,014 (+1%)
2025+2%$1,032 (+3%)
2024+18%$1,221 (+22%)
→ See Omnicell's full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Omnicell

Loading news…

📋 All analyst calls on OMCL

Piper Sandler 
Aug 3, 26
▲ Overweight · 🎯$45
Price at call : $37.15 — upside +21%
Today : $33.41 — upside +35%
🎯 on OMCL : 100% (2 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
in progress (365j)
matures : Aug 3, 27
Wells Fargo 
Jul 31, 26
▲ Overweight · 🎯$50
Price at call : $37.65 — upside +33%
Today : $33.41 — upside +50%
🎯 on OMCL : 100% (4 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Jul 31, 27
Keybanc 
Jul 31, 26
▲ Overweight · 🎯$65
Price at call : $35.37 — upside +84%
Today : $33.41 — upside +95%
🎯 on OMCL : 0% (1 call matured) · 📊 on Health : 25.2% · -18.3% (107 calls)
in progress (365j)
matures : Jul 31, 27
Keybanc 
Apr 29, 26
▲ Overweight · 🎯$70
Price at call : $41.42 — upside +69%
Today : $33.41 — upside +110%
🎯 on OMCL : 0% (1 call matured) · 📊 on Health : 25.2% · -18.3% (107 calls)
in progress (365j)
matures : Apr 29, 27
Wells Fargo 
Apr 23, 26
▲ Overweight · 🎯$55
Price at call : $37.37 — upside +47%
Today : $33.41 — upside +65%
🎯 on OMCL : 100% (4 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Apr 23, 27
Piper Sandler 
Feb 6, 26
▲ Overweight · 🎯$49
Price at call : $36.5 — upside +34%
Today : $33.41 — upside +47%
🎯 on OMCL : 100% (2 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
in progress (365j)
matures : Feb 6, 27
Benchmark 
Feb 2, 26
▲ Buy · 🎯$60
Price at call : $46.04 — upside +30%
Today : $33.41 — upside +80%
🎯 on OMCL : 42% (12 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
in progress (365j)
matures : Feb 2, 27
Keybanc 
Jan 8, 26
▲ Overweight · 🎯$60
Price at call : $50.59 — upside +19%
Today : $33.41 — upside +80%
🎯 on OMCL : 0% (1 call matured) · 📊 on Health : 25.2% · -18.3% (107 calls)
in progress (365j)
matures : Jan 8, 27
See the other 60 calls, newest to oldest
Wells Fargo 
Jan 5, 26
▲ Overweight · 🎯$52
Price at call : $47.07 — upside +10%
Today : $33.41 — upside +56%
🎯 on OMCL : 100% (4 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Jan 5, 27
■ Neutral neutral · not a buy · 🎯$46
Price at call : $43.97 — gap to target +5%
Today : $33.41 — gap to target +38%
🎯 on OMCL : 0% (1 call matured) · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : Dec 9, 26
Benchmark 
Dec 9, 25
▲ Buy · 🎯$50
Price at call : $43.49 — upside +15%
Today : $33.41 — upside +50%
🎯 on OMCL : 42% (12 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
in progress (365j)
matures : Dec 9, 26
Benchmark 
Oct 31, 25
▲ Buy · 🎯$45
Price at call : $33.37 — upside +35%
Today : $33.41 — upside +35%
🎯 on OMCL : 42% (12 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
in progress (365j)
matures : Oct 31, 26
Piper Sandler 
Aug 11, 25
▲ Overweight · 🎯$55
Price at call : $30.83 — upside +78%
Today : $33.41 — upside +65%
Expected +78% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on OMCL : 100% (2 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
+19.6%
stock +20% · XLV +29%
matured Aug 11, 26
Wells Fargo 
Jul 21, 25
▲ Overweight · 🎯$40
Price at call : $28.26 — upside +42%
Today : $33.41 — upside +20%
Expected +42% · Actual +45% · Reason (≥ +15%) : ✓ Yes
🎯 on OMCL : 100% (4 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
+44.6%
stock +45% · XLV +19%
matured Jul 21, 26
■ Neutral neutral · not a buy · 🎯$32
Price at call : $27.24 — gap to target +17%
Today : $33.41 — gap to target -4%
🎯 on OMCL : 0% (1 call matured) · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : Jul 14, 26
Wells Fargo 
May 23, 25
▲ Overweight · 🎯$37
Price at call : $29.61 — upside +25%
Today : $33.41 — upside +11%
Expected +25% · Actual +49% · Reason (≥ +15%) : ✓ Yes
🎯 on OMCL : 100% (4 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
+48.9%
stock +49% · XLV +12%
matured May 23, 26
■ Neutral neutral · not a buy · 🎯$34
Price at call : $29.61 — gap to target +15%
Today : $33.41 — gap to target +2%
🎯 on OMCL : 0% (1 call matured) · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : May 23, 26
Wells Fargo 
May 14, 25
▲ Overweight · 🎯$35
Price at call : $28.73 — upside +22%
Today : $33.41 — upside +5%
Expected +22% · Actual +52% · Reason (≥ +15%) : ✓ Yes
🎯 on OMCL : 100% (4 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
+52.4%
stock +52% · XLV +14%
matured May 14, 26
Benchmark 
May 7, 25
▲ Buy · 🎯$40
Price at call : $25.39 — upside +58%
Today : $33.41 — upside +20%
Expected +58% · Actual +73% · Reason (≥ +15%) : ✓ Yes
🎯 on OMCL : 42% (12 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
+72.6%
stock +73% · XLV +7%
matured May 7, 26
Wells Fargo 
May 7, 25
■ Equal-Weight neutral · not a buy · 🎯$31
Price at call : $25.39 — gap to target +22%
Today : $33.41 — gap to target -7%
🎯 on OMCL : 100% (4 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : May 7, 26
■ Neutral neutral · not a buy · 🎯$30
Price at call : $24.63 — gap to target +22%
Today : $33.41 — gap to target -10%
🎯 on OMCL : 0% (1 call matured) · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : May 7, 26
Wells Fargo 
Apr 17, 25
■ Equal-Weight neutral · not a buy · 🎯$38
Price at call : $29.65 — gap to target +28%
Today : $33.41 — gap to target +14%
🎯 on OMCL : 100% (4 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Apr 17, 26
JP Morgan 
Mar 20, 25
■ Neutral neutral · not a buy · 🎯$36
Price at call : $33.94 — gap to target +6%
Today : $33.41 — gap to target +8%
🎯 on OMCL : no call matured yet · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : Mar 20, 26
■ Neutral neutral · not a buy · 🎯$38
Price at call : $32.28 — gap to target +18%
Today : $33.41 — gap to target +14%
🎯 on OMCL : 0% (1 call matured) · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : Mar 13, 26
Benchmark 
Feb 4, 25
▲ Buy · 🎯$62
Price at call : $44.38 — upside +40%
Today : $33.41 — upside +86%
Expected +40% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on OMCL : 42% (12 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
-11.9%
stock -12% · XLV +4%
matured Feb 4, 26
Wells Fargo 
Jan 13, 25
■ Equal-Weight neutral · not a buy · 🎯$40
Price at call : $42.32 — gap to target -5%
Today : $33.41 — gap to target +20%
🎯 on OMCL : 100% (4 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Jan 13, 26
■ Neutral neutral · not a buy · 🎯$46
Price at call : $43.37 — gap to target +6%
Today : $33.41 — gap to target +38%
🎯 on OMCL : 0% (1 call matured) · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : Jan 6, 26
JP Morgan 
Nov 21, 24
■ Neutral neutral · not a buy · 🎯$44
Price at call : $45.69 — gap to target -4%
Today : $33.41 — gap to target +32%
🎯 on OMCL : no call matured yet · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : Nov 21, 25
Barclays 
Oct 31, 24
■ Equal-Weight neutral · not a buy · 🎯$58
Price at call : $48.67 — gap to target +19%
Today : $33.41 — gap to target +74%
🎯 on OMCL : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Oct 31, 25
Craig-Hallum 
Oct 31, 24
▲ Buy · 🎯$64
Price at call : $48.67 — upside +31%
Today : $33.41 — upside +92%
Expected +31% · Actual -31% · Reason (≥ +15%) : ✗ No
🎯 on OMCL : 40% (5 calls matureds) · 📊 on Health : 60.9% · +21.4% (23 calls)
-31.4%
stock -31% · XLV -2%
matured Oct 31, 25
■ Neutral neutral · not a buy · 🎯$57
Price at call : $48.64 — gap to target +17%
Today : $33.41 — gap to target +71%
🎯 on OMCL : 0% (1 call matured) · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : Oct 31, 25
Wells Fargo 
Oct 14, 24
■ Equal-Weight neutral · not a buy · 🎯$41
Price at call : $42.38 — gap to target -3%
Today : $33.41 — gap to target +23%
🎯 on OMCL : 100% (4 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Oct 14, 25
Benchmark 
Oct 9, 24
▲ Buy · 🎯$48
Price at call : $42.12 — upside +14%
Today : $33.41 — upside +44%
Expected +14% · Actual -29% · Reason (≥ +15%) : ✗ No
🎯 on OMCL : 42% (12 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
-29.4%
stock -29% · XLV -7%
matured Oct 9, 25
JP Morgan 
Aug 23, 24
■ Neutral neutral · not a buy · 🎯$37
Price at call : $44.8 — gap to target -17%
Today : $33.41 — gap to target +11%
🎯 on OMCL : no call matured yet · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : Aug 23, 25
Wells Fargo 
Aug 2, 24
■ Equal-Weight neutral · not a buy · 🎯$30
Price at call : $40 — gap to target -25%
Today : $33.41 — gap to target -10%
🎯 on OMCL : 100% (4 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Aug 2, 25
▲ Buy · 🎯$44
Price at call : $40 — upside +10%
Today : $33.41 — upside +32%
Expected +10% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on OMCL : 0% (1 call matured) · 📊 on Health : 51.3% · +3.0% (152 calls)
-23.9%
stock -24% · XLV -9%
matured Aug 2, 25
Barclays 
Aug 2, 24
■ Equal-Weight neutral · not a buy · 🎯$39
Price at call : $39.22 — gap to target -1%
Today : $33.41 — gap to target +17%
🎯 on OMCL : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Aug 2, 25
Benchmark 
Jul 15, 24
▲ Buy · 🎯$38
Price at call : $26.44 — upside +44%
Today : $33.41 — upside +14%
Expected +44% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on OMCL : 42% (12 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
+3.0%
stock +3% · XLV -10%
matured Jul 15, 25
Benchmark 
May 3, 24
▲ Buy · 🎯$38
Price at call : $29.98 — upside +27%
Today : $33.41 — upside +14%
Expected +27% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on OMCL : 42% (12 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
+1.7%
stock +2% · XLV -2%
matured May 3, 25
Benchmark 
Apr 30, 24
▲ Buy · 🎯$38
Price at call : $27.17 — upside +40%
Today : $33.41 — upside +14%
Expected +40% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on OMCL : 42% (12 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
+15.5%
stock +16% · XLV -3%
matured Apr 30, 25
Benchmark 
Feb 9, 24
▲ Buy · 🎯$38
Price at call : $28.9 — upside +31%
Today : $33.41 — upside +14%
Expected +31% · Actual +47% · Reason (≥ +15%) : ✓ Yes
🎯 on OMCL : 42% (12 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
+46.7%
stock +47% · XLV +1%
matured Feb 8, 25
Wells Fargo 
Feb 9, 24
■ Equal-Weight neutral · not a buy · 🎯$26
Price at call : $27.41 — gap to target -5%
Today : $33.41 — gap to target -22%
🎯 on OMCL : 100% (4 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Feb 8, 25
Wells Fargo 
Nov 3, 23
■ Equal-Weight neutral · not a buy · 🎯$28
Price at call : $30.44 — gap to target -8%
Today : $33.41 — gap to target -16%
🎯 on OMCL : 100% (4 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Nov 2, 24
BTIG 
Nov 3, 23
■ Neutral neutral · not a buy
🎯 on OMCL : 0% (5 calls matureds) · 📊 on Health : 46.2% · +19.8% (65 calls)
in progress (365j)
matures : Nov 2, 24
Piper Sandler 
Nov 3, 23
▲ Overweight · 🎯$39
Price at call : $30.44 — upside +28%
Today : $33.41 — upside +17%
Expected +28% · Actual +59% · Reason (≥ +15%) : ✓ Yes
🎯 on OMCL : 100% (2 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
+59.4%
stock +59% · XLV +15%
matured Nov 2, 24
Keybanc 
Oct 11, 23
■ Sector Weight neutral · not a buy
🎯 on OMCL : 0% (1 call matured) · 📊 on Health : 25.2% · -18.3% (107 calls)
in progress (365j)
matures : Oct 10, 24
Benchmark 
Oct 3, 23
▲ Buy · 🎯$70
Price at call : $43.94 — upside +59%
Today : $33.41 — upside +110%
Expected +59% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on OMCL : 42% (12 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
-5.5%
stock -6% · XLV +18%
matured Oct 2, 24
Wells Fargo 
Sep 26, 23
▼ Underweight · 🎯$39
Price at call : $44.6 — upside -13%
Today : $33.41 — upside +17%
Expected -13% · Actual -5% · Reason (≤ −15%) : ✗ No
🎯 on OMCL : 100% (4 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
+5.1%
stock -5% · XLV +19%
matured Sep 25, 24
Keybanc 
Aug 4, 23
▲ Overweight · 🎯$75
Price at call : $64.98 — upside +15%
Today : $33.41 — upside +124%
Expected +15% · Actual -38% · Reason (≥ +15%) : ✗ No
🎯 on OMCL : 0% (1 call matured) · 📊 on Health : 25.2% · -18.3% (107 calls)
-38.4%
stock -38% · XLV +11%
matured Aug 3, 24
Benchmark 
Aug 2, 23
▲ Buy · 🎯$88
Price at call : $63.88 — upside +38%
Today : $33.41 — upside +163%
Expected +38% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on OMCL : 42% (12 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
-38.6%
stock -39% · XLV +14%
matured Aug 1, 24
Benchmark 
Jul 31, 23
▲ Buy · 🎯$88
Price at call : $63.15 — upside +39%
Today : $33.41 — upside +163%
Expected +39% · Actual -53% · Reason (≥ +15%) : ✗ No
🎯 on OMCL : 42% (12 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
-53.5%
stock -53% · XLV +12%
matured Jul 30, 24
Benchmark 
Jun 15, 23
▲ Buy · 🎯$88
Price at call : $72.32 — upside +22%
Today : $33.41 — upside +163%
Expected +22% · Actual -61% · Reason (≥ +15%) : ✗ No
🎯 on OMCL : 42% (12 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
-61.4%
stock -61% · XLV +10%
matured Jun 14, 24
Benchmark 
Mar 1, 23
▲ Buy · 🎯$68
Price at call : $57.44 — upside +18%
Today : $33.41 — upside +104%
Expected +18% · Actual -54% · Reason (≥ +15%) : ✗ No
🎯 on OMCL : 42% (12 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
-54.1%
stock -54% · XLV +15%
matured Feb 29, 24
BTIG 
Nov 3, 22
▲ Buy · 🎯$75
Price at call : $53.88 — upside +39%
Today : $33.41 — upside +124%
Expected +39% · Actual -44% · Reason (≥ +15%) : ✗ No
🎯 on OMCL : 0% (5 calls matureds) · 📊 on Health : 46.2% · +19.8% (65 calls)
-43.5%
stock -44% · XLV -2%
matured Nov 3, 23
BTIG 
Sep 21, 22
▲ Buy · 🎯$160
Price at call : $90.82 — upside +76%
Today : $33.41 — upside +379%
Expected +76% · Actual -44% · Reason (≥ +15%) : ✗ No
🎯 on OMCL : 0% (5 calls matureds) · 📊 on Health : 46.2% · +19.8% (65 calls)
-43.8%
stock -44% · XLV +6%
matured Sep 21, 23
BTIG 
Jul 27, 22
▲ Buy · 🎯$175
Price at call : $110.31 — upside +59%
Today : $33.41 — upside +424%
Expected +59% · Actual -44% · Reason (≥ +15%) : ✗ No
🎯 on OMCL : 0% (5 calls matureds) · 📊 on Health : 46.2% · +19.8% (65 calls)
-44.0%
stock -44% · XLV +2%
matured Jul 27, 23
BTIG 
Dec 1, 21
▲ Buy · 🎯$220
Price at call : $176.39 — upside +25%
Today : $33.41 — upside +558%
Expected +25% · Actual -71% · Reason (≥ +15%) : ✗ No
🎯 on OMCL : 0% (5 calls matureds) · 📊 on Health : 46.2% · +19.8% (65 calls)
-71.1%
stock -71% · XLV +8%
matured Dec 1, 22
Craig-Hallum 
Nov 3, 21
▲ Buy · 🎯$205
Price at call : $177.34 — upside +16%
Today : $33.41 — upside +514%
Expected +16% · Actual -71% · Reason (≥ +15%) : ✗ No
🎯 on OMCL : 40% (5 calls matureds) · 📊 on Health : 60.9% · +21.4% (23 calls)
-70.8%
stock -71% · XLV -3%
matured Nov 3, 22
BTIG 
May 24, 21
▲ Buy · 🎯$165
Price at call : $137.05 — upside +20%
Today : $33.41 — upside +394%
Expected +20% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on OMCL : 0% (5 calls matureds) · 📊 on Health : 46.2% · +19.8% (65 calls)
-20.2%
stock -20% · XLV +5%
matured May 24, 22
▲ Overweight · 🎯$95
Price at call : $86.04 — upside +10%
Today : $33.41 — upside +184%
Expected +10% · Actual +101% · Reason (≥ +15%) : ✓ Yes
🎯 on OMCL : 100% (6 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+100.6%
stock +101% · XLV +29%
matured Oct 28, 21
▲ Overweight · 🎯$90
Price at call : $72.65 — upside +24%
Today : $33.41 — upside +169%
Expected +24% · Actual +95% · Reason (≥ +15%) : ✓ Yes
🎯 on OMCL : 100% (6 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+95.2%
stock +95% · XLV +24%
matured Jul 29, 21
▲ Overweight · 🎯$95
Price at call : $81.66 — upside +16%
Today : $33.41 — upside +184%
Expected +16% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on OMCL : 100% (6 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+43.0%
stock +43% · XLV +12%
matured Dec 10, 20
Craig-Hallum 
Jul 26, 19
▲ Buy · 🎯$85
Price at call : $75.25 — upside +13%
Today : $33.41 — upside +154%
Expected +13% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on OMCL : 40% (5 calls matureds) · 📊 on Health : 60.9% · +21.4% (23 calls)
-11.5%
stock -12% · XLV +15%
matured Jul 25, 20
▲ Overweight · 🎯$80
Price at call : $69.83 — upside +15%
Today : $33.41 — upside +139%
Expected +15% · Actual +15% · Reason (≥ +15%) : ✗ No
🎯 on OMCL : 100% (6 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+14.5%
stock +15% · XLV +10%
matured Dec 7, 19
▲ Overweight · 🎯$70
Price at call : $67.45 — upside +4%
Today : $33.41 — upside +110%
Expected +4% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on OMCL : 100% (6 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+4.0%
stock +4% · XLV +6%
matured Oct 26, 19
Craig-Hallum 
Jul 27, 18
▲ Buy
Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on OMCL : 40% (5 calls matureds) · 📊 on Health : 60.9% · +21.4% (23 calls)
+25.8%
stock +26% · XLV +5%
matured Jul 27, 19
▲ Overweight · 🎯$40
Price at call : $32.15 — upside +24%
Today : $33.41 — upside +20%
Expected +24% · Actual +57% · Reason (≥ +15%) : ✓ Yes
🎯 on OMCL : 100% (6 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+56.8%
stock +57% · XLV +19%
matured Jan 6, 18
Craig-Hallum 
Apr 9, 14
▲ Buy · 🎯$33
Price at call : $29.19 — upside +13%
Today : $33.41 — upside -1%
Expected +13% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on OMCL : 40% (5 calls matureds) · 📊 on Health : 60.9% · +21.4% (23 calls)
+21.7%
stock +22% · XLV +26%
matured Apr 9, 15

Frequently asked questions

Should I buy Omnicell stock?

This isn't buy advice. For Omnicell, the analyst consensus is "Buy", with an average price target of $50.00 (+50% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (6 calls tracked on Omnicell). We show the numbers — you decide.

Is it too late to buy Omnicell? How high can it go?

The most bullish analyst target on Omnicell is $65.00 (+95% above today's price); the average is $50.00. That's the upside they see. Check how reliable those analysts have actually been on Omnicell on our site before trusting it.

Is Omnicell still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 10 analysts have a real record on Omnicell, the best hitting 100% over 6 calls. Current consensus: "Buy". Make your call on data, not noise.

What has Omnicell's past performance been?

Historical returns and a "how much if I had invested" calculator: OMCL performance & returns.

What is the best month to buy OMCL?

The 12 months ranked by the stock's past returns: best & worst month to buy OMCL.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)